Error loading player: No playable sources found

AM24-MN-30-O

AM24-MN-30-O: Solve It! Scenarios in Apheresis and Cellular Therapy (Enduring)

Date
October 23, 2024
Credits
1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP) | 1.5 Physician (PHY)
$30
Standard Price
Members save $5
This product is also available as part of the following products:
Thumbnail for 2024 Annual Meeting On-Demand: FULL ACCESS
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…

We all face challenges in our daily work activities within Apheresis and Cellular Therapy: What are the resources to help with suitability determination in donors with significant comorbidities? How to optimize HPC(A) and biotherapy collections? How to optimize collections for cellular therapy in patients with hemoglobinopathy? What are factors that affect collection efficiency? How to best manage an apheresis network and how to prepare apheresis centers for biotherapy collections? What is the best approach to manage storage space? How to deal with supply and reagents shortages? How to handle the growing number of clinical trials? How to be better prepared for the next disaster? Or how to adjust training and competency programs to accommodate the changing workforce? The Solve It! Scenarios in Apheresis and Cellular Therapy session offers an interactive and constructive program for Apheresis and Cellular Therapy Professionals to share challenges through case scenario presentations. This program permits attendees to select topics of particular interest, rotate through multiple scenario case presentations in small, informal groups, and develop problem-solving strategies. Join us for lively interactions and networking with experts in the field of Apheresis and Cellular Therapy and fellow colleagues.

Learning Objectives

  • Manage common technical, clinical, and administrative challenges using case scenario approach.
  • Review regulatory requirements and accreditation standards while developing strategies to resolve mutual hurdles in daily practices.
  • Assemble with cellular therapy colleagues and experts in the field.

Moderator

Speaker Image for Vasiliki Kalodimou
Vasiliki Kalodimou, CABP (H), MSc, PhD
Director at Flow Cytometry - Research & Regenerative Medicine Department, IASO Maternity & Research Hospital, Athens Greece, Assistant Professor, School of Medicine at the European University-Cyprus Ltd. Frankfurt Branch, Board/Committee on Research Ethi, IASO Maternity Hospital

Related Products

Thumbnail for AM24-ST-29-O: Case Studies: Cyber Threats in Healthcare (Enduring)
AM24-ST-29-O: Case Studies: Cyber Threats in Healthcare (Enduring)
Join us for an essential panel discussion on cybersecurity in healthcare, where real-world insights and expert analysis come together to enhance your organization's defenses. This session features three distinguished speakers from hospitals and blood centers that have faced cybersecurity attacks…
Thumbnail for AM24-MN-41-O: The AABB Cellular Starting Material Forum: From Consent to Characterization - Enhancing Allogeneic Donor Practices (Enduring)
AM24-MN-41-O: The AABB Cellular Starting Material Forum: From Consent to Characterization - Enhancing Allogeneic Donor Practices (Enduring)
This session will delve into the critical elements of managing allogeneic cellular starting material for biotherapies…
Thumbnail for AM24-MN-36-O: From Courts to Congress: Navigating the Healthcare Policy Landscape in 2024 (Enduring)
AM24-MN-36-O: From Courts to Congress: Navigating the Healthcare Policy Landscape in 2024 (Enduring)
In today’s rapidly evolving healthcare environment, understanding the latest policy developments is crucial for strategic planning and operational success. This session will explore the significant implications of the recent Supreme Court decision – Loper Bright Enterprises v…
Thumbnail for AM24-ST-18-O: AABB RBC and Platelet International Guidelines: What is New: Liberally Restrictive and Restrictively Liberal? (Enduring)
AM24-ST-18-O: AABB RBC and Platelet International Guidelines: What is New: Liberally Restrictive and Restrictively Liberal? (Enduring)
The AABB continues to update and develop clinical transfusion guidelines as new evidence becomes available…